Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole for infants with symptomatic gastro-oesophageal reflux
ISRCTN31929591Phase 4Recruiting
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Jul 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Severity of gastro-oesophageal reflux symptoms. Started Jul 2026; status: recruiting.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ISRCTN31929591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31929591.